Приклади вживання Stada Англійська мовою та їх переклад на Українською
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
The company“STADA CIS” was the title sponsor.
It represents international pharmaceutical companies including Eli Lilly, Nizhpharm STADA and APRAD”.
Stada is a German pharmaceutical company founded in 1895.
As of December 31, 2018, STADA employed 10,416 people worldwide.
STADA expands German influence on the pharmaceutical market of Ukraine.
This social project helped STADA to get the award“Social company of the year”.
STADA Arzneimittel AG sells its products in approximately 20 countries.
He explains this by the fact that the volume ofproducts produced by contract factories for the company STADA is relatively small.
Alvotech and STADA agree on strategic biosimilar partnership.
So next year we will not be able to deliver to Ukraine up to ten drugs"-said the deputy director of STADA CIS Ivan Glushkov.
Stada is a German pharmaceutical company founded in 1895.
With this acquisition, we will become an important player in the Ukrainian pharma market with astrong local production footprint," emphasizes STADA CEO Peter Goldschmidt.
STADA Arzneimittel AG is a public company with headquarters in bad Vilbel(Germany).
August 8, 2012- Today, STADA Arzneimittel AG published the financial results for the first half of 2012.
STADA will integrate Walmark's high quality manufacturing facility in Trinec into STADA's global production network.
He added that the decision STADA to enter the Ukrainian market is the growth of confidence in Ukraine from the international business.
STADA makes one of the largest financial investment in the pharmaceutical sector of Ukraine is today one of the largest business investments in….
The German pharmaceutical company STADA buys the pharmaceutical business of prescription and over-the-counter drugs of the Biopharma manufacturer of blood-derived products.
Germany's STADA pharmaceutical company is acquiring pharmaceutical business of prescription and OTC preparations of Biopharma blood product manufacturer.
Bad Vilbel, December 2, 2019- The STADA Group, a global manufacturer of highquality generic drugs and consumer healthcare products, continues its growth trajectory in Europe.
STADA makes one of the largest financial investments in the Ukrainian pharmaceutical sector to date and one of the biggest business investments in Ukraine recently.
Further, Takeda and STADA will enter into manufacturing and supply agreements under which Takeda will continue to manufacture and supply the products to STADA.
STADA makes one of the largest financial investment in the pharmaceutical sector of Ukraine is today one of the largest business investments in Ukraine for the last time.
In addition, Takeda and STADA will enter into manufacturing and supply agreements in connection with the acquisition under which Takeda will continue to supply the products to STADA.
Stada signed an investment agreement with the consortium, which contains provisions aimed at protecting workplaces, manufacturing enterprises and the company's corporate strategy.
As a result of this acquisition, STADA has made one of the largest financial investments in the Ukrainian pharmaceutical sector to date and one of the biggest recent foreign investments in this country.
STADA CIS holding activities are aimed at ultimate revelation and satisfaction of needs related to gain in health of the customers who prefer modern and efficient medications.
As a result of this acquisition, STADA has implemented one of the largest financial investments in the pharmaceutical sector of Ukraine is today one of the largest foreign investments in the country recently.
To this end, STADA introduced new internal communications tools and encouraged employees worldwide to create more synergies and share knowledge.
Alvotech and global pharmaceutical company STADA Arzneimittel AG(“STADA”) today announced that they have entered into an exclusive strategic partnership for the commercialization of seven biosimilars in all key European markets and selected markets outside Europe.